Late preterm infant; Nationwide survey; Respiratory distress syndrome; Surfactant therapy
Abstract :
[en] Specific recommendations on surfactant administration in late preterm (LPT) infants with pulmonary disease are lacking. We performed an online-based, nationwide survey amongst all (n = 102) Belgian neonatologists to identify the use of surfactant in LPT infants suffering from several respiratory pathologies. The survey used clearly defined clinical cases and resulted in a 86% response rate. Neonatologists adhere to the 200 mg/kg initial surfactant dosing scheme. Surfactant is widely used in respiratory distress syndrome (70.1%), but there is less unanimity on its use in meconium aspiration syndrome (58.0%), transient tachypnoea of the newborn (30.6%), congenital pneumonia (27.2%) and congenital diaphragmatic hernia (8.6%). Respondents adhere to the European guideline of a timely referral to a newborn intensive care unit (non-invasive ventilation and FiO(2) > 0.30 at 12 h of age), in order to minimise the risk of deterioration.Conclusion: We demonstrate a wide variety in the use of surfactant within LPT infants. The majority of Belgian neonatologists therefore urge for an investment in multi-centre trials on surfactant administration in LPT infants, in order to create an evidence-based practice as well as to reduce the strain on health care budgets.Trial registration: https://clinicaltrials.gov What is Known: • Any late preterm (LPT) infant with respiratory distress needs a timely referral to a neonatal intensive care unit in case of non-invasive ventilation and FiO(2) > 0.30 at 12 h of life, in order to minimise the risk of acute deterioration as well as chronic lung disease. • Any modest increase in morbidity in the sizeable group of LPT infants exerts a significant strain on health care budgets. What is New: • We report the attitudes and opinions of Belgian neonatologists about the use of surfactant in LPT infants suffering from several respiratory diseases. • Our survey demonstrates a significant variability in practice between neonatologists during treatment of respiratory pathologies in LPT infants. This highlights an urgent need for univocal therapeutic lines.
Disciplines :
Pediatrics
Author, co-author :
Cornette, L.
Mulder, A.
DeBeer, Ann
Malfilâtre, G.
Rigo, Vincent ; Université de Liège - ULiège > Département des sciences cliniques > Néonatologie
Cools, F.
Danhaive, O.
Language :
English
Title :
Surfactant use in late preterm infants: a survey among Belgian neonatologists.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Escobar GJ, Clark RH, Greene JD (2006) Short-term outcomes of infants born at 35 and 36 weeks gestation: we need to ask more questions. Semin Perinatol 30(1):28–33 DOI: 10.1053/j.semperi.2006.01.005
Boyle JD, Boyle EM (2013) Born just a few weeks early: does it matter? Arch Dis Child Fetal Neonatal Ed 98(1):F85–F88 DOI: 10.1136/archdischild-2011-300535
Teune MJ, Bakhuizen S, Gyamfi Bannerman C et al (2011) A systematic review of severe morbidity in infants born late preterm. Am J Obstet Gynecol 205(4):374.e1–374.e9 DOI: 10.1016/j.ajog.2011.07.015
Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, te Pas A, Plavka R, Roehr CC, Saugstad OD, Simeoni U, Speer CP, Vento M, Visser GHA, Halliday HL (2019) European consensus guidelines on the management of respiratory distress syndrome - 2019 update. Neonatology. 115(4):432–450 DOI: 10.1159/000499361
Dani C, Mosca F, Vento G, Tagliabue P, Picone S, Lista G, Fanos V, Pratesi S, Boni L (2018) Effects of surfactant treatment in late preterm infants with respiratory distress syndrome. J Matern Fetal Neonatal Med 31(10):1259–1266 DOI: 10.1080/14767058.2017.1313828
Bancalari EH, Jobe AH (2012) The respiratory course of extremely preterm infants: a dilemma for diagnosis and terminology. J Pediatr 161(4):585–588 DOI: 10.1016/j.jpeds.2012.05.054
Kelley K, Clark B, Brown V, Sitzia J (2003) Good practice in the conduct and reporting of survey research. Int J Qual Health Care 15(3):261–266 DOI: 10.1093/intqhc/mzg031
Isayama T, Chai-Adisaksopha C, McDonald SD (2015) Noninvasive ventilation with vs without early surfactant to prevent chronic lung disease in preterm infants: a systematic review and meta-analysis. JAMA Pediatr 169(8):731–739 DOI: 10.1001/jamapediatrics.2015.0510
Banerjee S, Fernandez R, Fox GF, Goss KCW, Mactier H, Reynolds P, Sweet DG, Roehr CC (2019) Surfactant replacement therapy for respiratory distress syndrome in preterm infants: United Kingdom national consensus. Pediatr Res 86(1):12–14 DOI: 10.1038/s41390-019-0344-5
Brat R, Yousef N, Klifa R, Reynaud S, Shankar Aguilera S, de Luca D (2015 Aug) Lung ultrasonography score to evaluate oxygenation and surfactant need in neonates treated with continuous positive airway pressure. JAMA Pediatr 169(8):e151797 DOI: 10.1001/jamapediatrics.2015.1797
Raimondi F, Yousef N, Rodriguez Fanjul J, de Luca D, Corsini I, Shankar-Aguilera S, Dani C, di Guardo V, Lama S, Mosca F, Migliaro F, Sodano A, Vallone G, Capasso L (2019) A multicenter lung ultrasound study on transient tachypnea of the neonate. Neonatology. 115(3):263–268 DOI: 10.1159/000495911
Gregorio-Hernández R, Arriaga-Redondo M, Pérez-Pérez A, Ramos-Navarro C, Sánchez-Luna M (2020) Lung ultrasound in preterm infants with respiratory distress: experience in a neonatal intensive care unit. Eur J Pediatr 179(1):81–89 DOI: 10.1007/s00431-019-03470-0
Crocker C, Courtney SE, van Kaam A, et al. The Neonatal ARDS Worldwide Network: summary on patient data on respiratory support, course and outcomes. Pediatr Acad Soc 2019 Meeting, abstract 3164737.
De Luca D, van Kaam AH, Tingay DG et al (2017) The Montreux definition of neonatal ARDS: biological and clinical background behind the description of a new entity. Lancet Respir Med 5(8):657–666 DOI: 10.1016/S2213-2600(17)30214-X
Herting E, Gefeller O, Land M, van Sonderen L, Harms K, Robertson B, Members of the Collaborative European Multicenter Study Group (2000) Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Pediatrics. 106:957–964 DOI: 10.1542/peds.106.5.957
Tan K, Lai NM, Sharma A (2012) Surfactant for bacterial pneumonia in late preterm and term infants. Cochrane Database Syst Rev 2:CD008155
Lotze A, Knight GR, Martin GR, Bulas DI, Hull WM, O'Donnell RM, Whitsett JA, Short BL (1993) Improved pulmonary outcome after exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxygenation. J Pediatr 122(2):261–268 DOI: 10.1016/S0022-3476(06)80131-9
Natarajan CK, Sankar MJ, Jain K, Agarwal R, Paul VK (2016) Surfactant therapy and antibiotics in neonates with meconium aspiration syndrome: a systematic review and meta-analysis. J Perinatol 36(Suppl 1):S49–S54 DOI: 10.1038/jp.2016.32
Rais-Bahrami K, Rivera O, Seale WR, Short BL (1997) Effect of nitric oxide in meconium aspiration syndrome after treatment with surfactant. Crit Care Med 25(10):1744–1747 DOI: 10.1097/00003246-199710000-00027
El Shahed AI, Dargaville PA, Ohlsson A et al (2014) Surfactant for meconium aspiration syndrome in term and late preterm infants. Cochrane Database Syst Rev 12:CD002054
Lally KP, Lally PA, Langham MR, Hirschl R, Moya FR, Tibboel D, van Meurs K, Congenital Diaphragmatic Hernia Study Group (2004) Congenital Diaphragmatic Hernia Study Group. Surfactant does not improve survival rate in preterm infants with congenital diaphragmatic hernia. J Pediatr Surg 39(6):829–833 DOI: 10.1016/j.jpedsurg.2004.02.011
Cogo PE, Simonato M, Danhaive O, Verlato G, Cobellis G, Savignoni F, Peca D, Baritussio A, Carnielli VP (2013) Impaired surfactant protein B synthesis in infants with congenital diaphragmatic hernia. Eur Respir J 41(3):677–682 DOI: 10.1183/09031936.00032212
Jourdain G, Zacaria F, Ammar F, De Luca D (2016) Appropriateness of surfactant dosing for preterm babies with respiratory distress syndrome: retrospective cohort study. Arch Dis Child Fetal Neonatal Ed 101(2):F182–F183 DOI: 10.1136/archdischild-2015-310195
Boix H, Rite S, Arruza L, Fernandez C, Serrano I, Baquedano I, Sanchez A, Ferreira E, Fernandez P, Gonzalez R, Elorza MD (2019) Underdosing of surfactant for preterm babies with respiratory distress syndrome in clinical practice: a retrospective cohort study. Am J Perinatol 36(9):943–948 DOI: 10.1055/s-0038-1675645
Foligno S, De Luca D (2020) Porcine versus bovine surfactant therapy for RDS in preterm neonates: pragmatic meta-analysis and review of physiopathological plausibility of the effects on extra-pulmonary outcomes. Respir Res 21(1):8 DOI: 10.1186/s12931-019-1267-8
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
